Today's Low
₹ 222.35
Today's High
₹ 224.35
52 Weeks Low
₹ 62.90
52 Weeks High
₹ 185.05
Lower
₹ 203.05
Upper
₹ 224.35
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company provides polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also offers drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4amino pyridine, and 2chloro5nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 23.7 | 25.6 | 17.8 | 21.4 | 27.3 | 18.7 | 17.7 | 11.6 | 7.9 | 5.5 |
Total Non-Current Assets | 15.0 | 15.4 | 15.7 | 15.5 | 16.6 | 17.0 | 17.6 | 14.5 | 9.5 | 3.4 |
Total Assets | 38.7 | 41.1 | 33.6 | 37.2 | 44.1 | 35.7 | 35.2 | 26.0 | 17.4 | 8.9 |
Total Current Liabilities | 13.5 | 18.3 | 12.5 | 16.7 | 21.3 | 14.8 | 14.2 | 8.7 | 6.4 | 1.5 |
Total Non-Current Liabilities | 1.2 | 1.3 | 2.4 | 4.0 | 8.6 | 16.7 | 18.4 | 15.9 | 8.0 | 7.3 |
Shareholder's Funds | 23.9 | 21.4 | 18.8 | 16.5 | 14.2 | 4.2 | 2.6 | 1.4 | 3.1 | 0.1 |
Total Liabilities | 38.7 | 41.1 | 33.6 | 37.2 | 44.1 | 35.7 | 35.2 | 26.0 | 17.4 | 8.9 |
The Industry Debt to Equity Ratio stands at 0.37, vs the Debt to Equity Ratio of 0.04, which results in a Positive aspect.
The Industry Quick Ratio stands at 1.42, vs the Quick Ratio of 1.92, which results in a Positive aspect.
The Industry Current Ratio stands at 2.17, vs the Current Ratio of 2.44, which results in a Positive aspect.
The Industry Price to BV stands at 10.49, vs the Price to BV of 9.02, which results in a Negative aspect.
Particulars | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
---|---|---|---|---|---|---|---|---|---|---|
Total Income | 40.3 | 47.4 | 45.4 | 54.9 | 47.8 | 34.4 | 26.8 | 13.0 | 11.8 | 3.4 |
Total Expenditure | 34.7 | 41.3 | 39.4 | 48.7 | 40.6 | 28.8 | 22.1 | 10.9 | 10.0 | 3.3 |
Operating Profit(Excl OI) | 6.1 | 6.6 | 6.4 | 6.5 | 7.4 | 6.4 | 5.1 | 2.2 | 1.9 | 0.3 |
Add: Other Income | 0.5 | 0.6 | 0.4 | 0.4 | 0.2 | 0.8 | 0.4 | 0.1 | 0.0 | 0.1 |
Operating Profit | 6.1 | 6.6 | 6.4 | 6.5 | 7.4 | 6.4 | 5.1 | 2.2 | 1.9 | 0.3 |
Less: Interest | 0.4 | 0.6 | 1.0 | 1.6 | 3.3 | 3.5 | 3.1 | 2.5 | 1.6 | 0.2 |
PBDT | 5.8 | 6.1 | 5.4 | 4.9 | 4.1 | 2.9 | 2.0 | -0.3 | 0.3 | 0.1 |
Less: Depreciation Amortization | 2.3 | 2.4 | 2.3 | 2.4 | 2.2 | 2.1 | 1.5 | 0.7 | 0.2 | 0.0 |
PBT & Exceptional Items | 3.5 | 3.6 | 3.1 | 2.5 | 1.9 | 0.9 | 0.5 | -1.0 | 0.0 | 0.1 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | 3.5 | 3.6 | 3.1 | 2.5 | 1.9 | 0.9 | 0.5 | -1.0 | 0.0 | 0.1 |
Less: Taxation | 0.9 | 1.0 | 0.8 | 0.3 | 0.8 | -0.7 | 0.4 | 0.6 | 0.0 | 0.0 |
Profit After Tax | 2.6 | 2.7 | 2.3 | 2.3 | 1.1 | 1.6 | 0.2 | -1.7 | 0.0 | 0.0 |
Earnings Per Share | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
The Industry PAT Margin stands at 13.19, vs the PAT Margin of 6.71, which results in a Negative aspect.
The Industry Dividend Yield stands at 0.42, vs the Dividend Yield of 0.00, which results in a Negative aspect.
The Industry PAT Growth stands at 32.62, vs the PAT Growth of 60.04, which results in a Positive aspect.
The Industry PE Ratio stands at 58.81, vs the PE Ratio of 276.78, which results in a Positive aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | 6.2 | 3.4 | 3.6 | 3.1 | 2.5 | 1.9 | 0.9 | 0.5 | -1.0 | 0.0 | 0.1 |
Tax Paid | -1.7 | -0.9 | -1.0 | -0.8 | -0.3 | -0.8 | 0.7 | 0.0 | 0.0 | 0.0 | 0.0 |
Adjustment | 2.2 | 2.3 | 2.4 | 2.9 | 3.5 | 5.4 | 5.0 | 4.5 | 3.1 | 1.8 | 0.1 |
Changes In Working Capital | 6.2 | 3.4 | 3.6 | 3.1 | 2.5 | 1.9 | 0.9 | 0.5 | -1.0 | 0.0 | 0.1 |
Cash Flow after changes in Working Capital | 4.7 | 5.0 | 2.7 | 11.1 | 9.8 | 6.6 | 3.3 | 6.2 | 8.6 | -0.3 | 3.9 |
Cash Flow from Operating Activities | 2.9 | 4.0 | 1.7 | 10.3 | 9.5 | 6.0 | 4.0 | 6.2 | 8.6 | -0.3 | 3.9 |
Cash Flow from Investing Activities | -1.3 | 0.1 | -0.6 | -3.1 | -2.8 | -1.2 | -1.4 | -4.5 | -5.6 | -6.3 | -3.2 |
Cash Flow from Financing Activities | -2.4 | -6.1 | 4.5 | -9.9 | -4.9 | -3.8 | -2.9 | -1.3 | -2.3 | 6.6 | -0.6 |
Net Cash Inflow / Outflow | -0.7 | -2.0 | 5.6 | -2.7 | 1.7 | 1.0 | -0.3 | 0.5 | 0.7 | 0.1 | 0.0 |
Opening Cash & Cash Equivalents | 1.3 | 6.6 | 1.0 | 3.6 | 2.0 | 1.0 | 1.3 | 0.8 | 0.1 | 0.0 | 0.0 |
Closing Cash & Cash Equivalent | 0.5 | 4.6 | 6.6 | 1.0 | 3.6 | 2.0 | 1.0 | 1.3 | 0.8 | 0.1 | 0.0 |
The Industry PCF RATIO stands at 1.34, vs the PCF RATIO of 33.11, which results in a Positive aspect.
The Industry PFCF Ratio stands at -109.98, vs the PFCF Ratio of 90.40, which results in a Positive aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 77.0 | 89.1 | 76.0 | 125.6 | 162.5 | 227.4 | 181.8 | 126.7 | 79.0 | 107.0 | 90.6 | 88.5 |
Total Income | 78.9 | 90.0 | 76.9 | 126.2 | 163.2 | 228.0 | 182.0 | 128.8 | 80.2 | 107.7 | 91.2 | 91.4 |
Total Expenditure | 71.7 | 82.2 | 66.1 | 114.0 | 145.1 | 194.8 | 159.2 | 111.3 | 68.9 | 90.1 | 76.4 | 78.0 |
PBIDT (Excl OI) | 5.2 | 6.9 | 9.8 | 11.6 | 17.4 | 32.6 | 22.6 | 15.4 | 10.1 | 16.9 | 14.3 | 10.5 |
Other Income | 1.9 | 0.9 | 0.9 | 0.6 | 0.7 | 0.6 | 0.2 | 2.1 | 1.2 | 0.7 | 0.6 | 2.9 |
Operating Profit | 7.2 | 7.8 | 10.7 | 12.2 | 18.1 | 33.2 | 22.8 | 17.5 | 11.3 | 17.7 | 14.8 | 13.4 |
Interest | 0.5 | 0.8 | 0.7 | 0.7 | 0.9 | 1.1 | 1.1 | 0.9 | 0.9 | 0.6 | 1.2 | 0.9 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 6.7 | 7.0 | 10.0 | 11.5 | 17.2 | 32.1 | 21.7 | 16.6 | 10.4 | 17.1 | 13.7 | 12.4 |
Depreciation | 3.5 | 4.2 | 3.5 | 4.8 | 4.9 | 4.8 | 6.4 | 6.2 | 3.8 | 6.7 | 6.6 | 6.2 |
Profit Before Tax | 3.2 | 2.8 | 6.5 | 6.7 | 12.3 | 27.4 | 15.2 | 10.4 | 6.7 | 10.4 | 7.1 | 6.3 |
Tax | 0.8 | 0.7 | 1.6 | 6.6 | 3.1 | 6.9 | 3.8 | 2.5 | 1.3 | 3.1 | 1.8 | 2.0 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 2.4 | 2.1 | 4.9 | 0.1 | 9.2 | 20.5 | 11.4 | 7.9 | 5.3 | 7.3 | 5.3 | 4.3 |
Net Profit | 2.4 | 2.1 | 4.9 | 0.1 | 9.2 | 20.5 | 11.4 | 7.9 | 5.3 | 7.3 | 5.3 | 4.3 |
ADDITIONAL INFOS: | ||||||||||||
Equity Capital | 110.2 | 110.2 | 110.2 | 110.2 | 110.2 | 110.2 | 110.2 | 110.2 | 110.2 | 110.2 | 110.2 | 110.2 |
Reserves | 179.8 | 177.4 | 175.3 | 170.4 | 170.3 | 161.1 | 140.6 | 0.0 | 0.0 | 116.7 | 0.0 | 0.0 |
EPS | 0.2 | 0.2 | 0.4 | 0.0 | 0.8 | 1.9 | 1.0 | 0.7 | 0.5 | 0.7 | 0.5 | 0.4 |
Operating Profit Margin | 9.3 | 8.8 | 14.1 | 9.7 | 11.1 | 14.6 | 12.5 | 13.8 | 14.3 | 16.5 | 16.4 | 15.1 |
Net Profit Margin | 3.1 | 2.4 | 6.4 | 0.1 | 5.7 | 9.0 | 6.3 | 6.2 | 6.8 | 6.8 | 5.8 | 4.9 |
The Industry Mcap Growth stands at -5.06, vs the Mcap Growth of -22.60, which results in a Negative aspect.
The Industry Net Sales Growth stands at 28.30, vs the Net Sales Growth of 52.12, which results in a Positive aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 228.35 | 229.85 | 225.45 |
R3 | 227.02 | 227.35 | 224.90 |
R2 | 225.68 | 225.85 | 224.72 |
R1 | 225.02 | 225.35 | 224.53 |
Pivot | 223.68 | 223.85 | 223.68 |
S1 | 223.02 | 223.35 | 224.17 |
S2 | 221.68 | 221.85 | 223.98 |
S3 | 221.02 | 221.35 | 223.80 |
S4 | 220.35 | 217.85 | 223.25 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
24.56
Neutral
RSI
60.05
Neutral
ROC
40.17
Bullish
UltimateOscillator
29.20
Bearish
Williams Indicator
-51.21
Neutral
CCI Indicator
22.33
Neutral
MACD
-2,772.83
Bearish
Stochastic Indicator
51.23
Neutral
ATR
15.43
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|
Date Of Conduct | Board Meeting Details |
---|---|
13-02-2024 | ARVEE LABORATORIES (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 . |
09-02-2024 | Financial Results |
07-11-2023 | Financial Results/Other business matters |
11-08-2023 | Financial Results/Other business matters |
05-05-2023 | Financial Results/Other business matters |
02-02-2023 | Financial Results/Other business matters |
11-11-2022 | Financial results/Other business matters |
02-08-2022 | Financial results/Other business matters |
27-06-2022 | Other business matters |
26-05-2022 | Financial results/Other business matters |
08-02-2022 | Financial Results/Other business matters |
12-11-2021 | Financial Results/Other business matters |
17-07-2021 | Financial Results/Other business matters |
17-06-2021 | Financial Results/Other business matters |